API reference
Betahistine
- CAS number
- 5638-76-6
- Molecular formula
- C8H12N2
- Molecular weight
- 136.19 g/mol
About this molecule
Ménière's disease is a progressive disease of the inner ear characterized by vertigo, tinnitus, and hearing loss. It has a significant impact on both the physical and social functioning of affected individuals. Betahistine is a histamine-like antivertigo drug used for treating symptoms associated with Ménière's disease. It is thought to reduce symptoms through its actions on histamine receptors. Betahistine was first approved by the FDA in the 1970s but withdrawn within approximately 5 years due to a lack of evidence supporting its efficacy. It is currently marketed in Canada by various companies, including Teva Pharmaceuticals.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- N-methyl-2-pyridin-2-ylethanamine
- InChIKey
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N
- SMILES
- CNCCC1=CC=CC=N1
- PubChem CID
- 2366
Also known as
betahistine · N-Methyl-2-pyridineethanamine · Vasomotal · 2-Pyridineethanamine, N-methyl- · Betahistina · N-methyl-2-pyridin-2-ylethanamine · Betahistinum · Betaistina
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.